Department of ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2090177. doi: 10.1080/21645515.2022.2090177. Epub 2022 Jun 22.
Rare cases of viral keratitis after coronavirus disease 2019 (COVID-19) vaccination have been reported. Furthermore, to our knowledge, cases of viral keratitis after two rounds of COVID-19 vaccination have not yet been reported. We report the case of a 19-year-old man without a history of keratitis, who developed viral keratitis soon after receiving the second and third doses of inactivated COVID-19 vaccines. Each time after the patient received treatment with topical and systemic drugs, his ocular symptoms were gradually relieved, and corrected visual acuity in both eyes returned to normal. COVID-19 vaccination may be associated with rare cases of the development of keratitis in individuals without a medical history of keratitis. Physicians should be aware of the possible relationship between ocular symptoms and adverse reactions to the COVID-19 vaccination. Despite the potential risks of COVID-19 vaccination, the benefits of immunization against the virus far outweigh these risks.
有报道称，新冠病毒病（COVID-19）疫苗接种后罕见病毒性角膜炎病例。此外，据我们所知，尚未有报道称 COVID-19 疫苗接种两剂后发生病毒性角膜炎病例。我们报告了一例无角膜炎病史的 19 岁男性，在接种两剂和第三剂灭活 COVID-19 疫苗后很快发生病毒性角膜炎。每次患者接受局部和全身药物治疗后，眼部症状逐渐缓解，双眼矫正视力恢复正常。COVID-19 疫苗接种可能与无角膜炎病史个体发生角膜炎的罕见病例有关。医生应意识到眼部症状与 COVID-19 疫苗接种不良反应之间可能存在的关系。尽管 COVID-19 疫苗接种存在潜在风险，但接种疫苗预防该病毒的益处远远超过这些风险。
